SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Ernest Hemingway — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientErnest Hemingway
Date of birth1899-07-21
IdentifiersMRN HR-ET003-SYN-TD; SSN (made up) 000-03-7419
Document date1955-07-27
AuthorWalter Brandt-Ochoa, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Hemingway is a 56-year-old writer with hereditary hemochromatosis on weekly phlebotomy, severe alcohol use disorder with no alcohol for about two months, depression on sertraline 100 mg, hypertension on amlodipine 10 mg, post-concussion symptoms and prediabetes, who comes for his yearly preventive visit seven weeks after his fourteen-week review. His hand healed fully after the antibiotics. He has had seventeen phlebotomy sessions so far, with the eighteenth today, and tolerates them well. He has had no alcohol since he chose to stop, takes naltrexone daily, and has fewer cravings. His mood is better and his PHQ-9 today is 6. His home blood pressure average is 126/78. He has headaches about once a week and is writing every morning again. His guns remain in the locked storage at his shooting club. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 56
AlcoholNone for about two months
PhlebotomySeventeen sessions; the eighteenth today; tolerated well
MoodPHQ-9 6; item 9 scored 0
MedicinesNaltrexone 50 mg, sertraline 100 mg, amlodipine 10 mg and thiamine 100 mg daily

Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Brandt-Ochoa. [S]

DomainFinding
Self-rated healthGood, and better than in the spring
PsychosocialWeekly psychotherapy; writing every morning; close friends from fishing and hunting
Substance useNo alcohol for about two months; no other drugs
TobaccoDoes not smoke
Physical activitySwims most days and walks; back stiffness limits long walks
NutritionEats fish and vegetables; no iron or vitamin C supplements; no raw shellfish
SleepSix to seven hours on most nights
Hearing and visionSome hearing loss in noisy rooms after years of shooting; reads with glasses
Safety at homeFeels safe at home; firearms stored off-site at his shooting club
Road and water safetyWears a seat belt; wears a life jacket on the boat in rough weather
Activities of daily livingIndependent
Oral healthDental visit in the past year

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or night sweats; weight down 4 kg since the spring, as he wished
EyesNegativeNo change in vision
Ears, nose, mouth, and throatPositiveSome difficulty hearing in noisy rooms; no ear pain
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo abdominal pain, blood in the stool or change in bowel habit
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalPositiveLower back stiffness since the crashes; no new joint pain
IntegumentaryNegativeHand wound healed; no new skin lesions
NeurologicalPositiveHeadaches about once a week; no weakness or numbness
PsychiatricNegativeMood better; PHQ-9 6; no thoughts of suicide or self-harm

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinkingOne tablet dailyOral route1955-03-02activeS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-08-31completedS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-04-13completedS
Sertraline 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-04-13activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-03-02 to 1955-06-08completedS
Amlodipine 10 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-06-08activeS
Cephalexin 500 mg oral capsule, one capsule four times daily for seven daysOne capsule four times daily for seven daysOral route1955-05-11 to 1955-05-18completedS
Doxycycline hyclate 100 mg oral capsule, one capsule twice daily for seven days, with a full glass of water, sitting uprightOne capsule twice daily for seven daysOral route1955-05-11 to 1955-05-18completedS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for pain, no more than 2,000 mg a day while he is drinkingOne or two tablets every 6 hours as needed, up to 2,000 mg a dayOral route1955-05-11 to 1955-05-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1955-07-27Body height183cmS
1955-07-27Body weight93.6kgS
1955-07-27Body mass index (BMI) [Ratio]27.9kg/m2S
1955-07-27Systolic blood pressure128mm[Hg]S
1955-07-27Diastolic blood pressure80mm[Hg]S
1955-07-27Heart rate74/minS
1955-07-27Respiratory rate14/minS
1955-07-27Body temperature36.6CelS
1955-07-27Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1955-07-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 1955-07-27; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 93.6 kg, BMI 27.9; blood pressure 128/80; pulse 74
EyesPupils equal and reactive; fundi without hypertensive changes
EarsCanals clear; whispered voice test reduced on the right
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; liver edge not palpable; no spleen felt
SkinHand healed; sun damage on the face and forearms without a suspicious lesion; no bronze pigmentation
MusculoskeletalLumbar movement mildly limited; no joint swelling
PsychiatricCalm and engaged; good humor

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding of DSM-5-TR severe alcohol use disorder (seven criteria); person-first language; not a claim about his real diagnosis.
Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload)resolvedconfirmed R79.0S — Synthetic presenting finding; superseded when HFE testing gave the diagnosis.
Hereditary hemochromatosis, HFE C282Y homozygous, with iron overload (ferritin over 1,000 ng/mL) and no advanced liver fibrosis on imagingactiveconfirmed E83.110S — Synthetic modern diagnosis. Whether he had hemochromatosis is disputed (CLM-0013); the modern diagnosis is not offered as proof of it.
Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about his real mood. The roster's bipolar disorder lead is disputed (CLM-0014) and is not used.
Essential hypertension, stage 2, with heavy drinking contributingactiveconfirmed I10S — Synthetic modern diagnosis confirmed by home readings.
Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosedactiveconfirmed F07.81S — Synthetic modern diagnosis anchored to his documented head injuries; alcohol and depression also affect the symptoms.
Prediabetes (HbA1c 6.1%)activeconfirmed R73.03S — Synthetic finding on diabetes screening; iron overload and alcohol both raise the risk of diabetes.
Fishhook puncture wound of the right hand with early cellulitis after saltwater exposure, in a man with iron overload; treated with antibiotics covering Vibrio; resolvedresolvedconfirmed L03.113S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today128/80 mmHg on treatment; home average 126/78
Colorectal cancer screeningOrderedAges 45 to 75; no screening before; colonoscopy ordered
Prostate cancer screeningDeclinedShared decision-making for ages 55 to 69; he chose not to have a PSA test this year
Lung cancer screeningNot indicatedNever a cigarette smoker
Diabetes screeningUp to dateHbA1c 6.1% at intake (prediabetes); repeat at the six-month visit
Statin for primary preventionDueEstimated 10-year cardiovascular risk about 7% at intake; lipids to be repeated at the six-month visit after months without alcohol, then a shared decision
HIV screeningUp to dateNonreactive at intake
Hepatitis C screeningUp to dateAntibody nonreactive at intake
Hepatitis B screeningUp to dateTriple panel nonreactive at intake; not immune, so vaccination started
Depression screeningCompleted todayPHQ-9 6, from 16 at intake; item 9 scored 0; in treatment
Unhealthy alcohol useUp to dateAUDIT 26 at intake; in treatment; no alcohol for about two months
Tobacco useCompleted todayDoes not smoke
Pneumococcal vaccineCompleted todayPCV20 today for chronic liver disease and alcohol use disorder
Zoster vaccineCompleted todayRecombinant vaccine dose 1 of 2; dose 2 in two to six months
Hepatitis A and B vaccinesCompleted todayCombined vaccine dose 1 of 3, for chronic liver disease
Tetanus, diphtheria, and pertussisUp to dateTdap at the sick visit in the spring
Influenza vaccineDueNext season's vaccine in the autumn

Immunizations given today: Pneumococcal conjugate vaccine (PCV20), one dose for chronic liver disease and alcohol use disorder; Recombinant zoster vaccine, dose 1 of 2; Hepatitis A and hepatitis B vaccine, dose 1 of 3, for chronic liver disease after nonreactive hepatitis B tests [S]

Guideline basis: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Six-month review in five weeks with iron studies, liver tests, HbA1c, lipids and the repeat MoCA. Weekly phlebotomy continues. Colonoscopy to be scheduled. Second zoster and hepatitis vaccine doses due. Next preventive visit in one year. Next scheduled visit 1955-08-31: six-month review: iron, liver, mood, memory and the plan for maintenance phlebotomy. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 18 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think clearly and write, and being outdoors. He chose not to record specific treatment preferences today and asked to return to the subject when his treatment is further along. The plan will be revisited yearly or after any serious illness. [S]